Respira Therapeutics' Series B Round

Respira Therapeutics raised a round of funding on April 26, 2017.

Respira is a product development-stage company focused on pulmonary delivery of therapeutics for respiratory diseases with unmet medical needs. The company realized seed capitalization from the Cotton…

Articles about Respira Therapeutics' Series B Round: